SABCS 2024: AI-driven feature discovery enables accurate identification of breast cancer biomarkers and histology
Empowering physicians with advanced multi-modal tools to improve treatment selection and patient outcomes.
Back To Top
Ataraxis AI wprowadza Ataraxis Breast, pierwszy test dla raka piersi oparty o sztuczną inteligencję